ABSTRACT-To develop a model to predict the efficacy and adversity of class I antiarrhythmic drugs, intra ventricular conduction time (IVCT), coronary blood flow (CBF), developed tension of papillary muscle (DT) and idioventricular automaticity rate (VR) were measured following drug administration in an isolated canine papillary muscle preparation cross-circulated with the heparinized blood of a donor dog. Tetrodo toxin, the prototypic fast Na+ channel blocker, and class I drugs increased IVCT and CBF, but decreased DT and VR, in a dose-dependent manner. The profiles of known class I drugs, procainamide, disopyramide, lidocaine, mexiletine and flecainide were similar, but the potencies of each drug were different. Two new class I drugs, ME3202 and AN-132, were also tested and found to have effects that were similar to that of tetrodotoxin. There was a good correlation between the doses of drugs prolonging IVCT by 50010 and the canine antiarrhythmic plasma concentrations in our previous study. This model can also be used to estimate the use-dependency and the kinetics of use-dependent sodium channel block; however, it is not suitable for extensive investigation of cellular and molecular mechanisms. Thus, the use of this model facilitates the com parison of multiple cardiac effects of class I drugs and may be an effective way to better assess new antiar rhythmic drugs.
(CAST), in which the patients who received class I drugs to suppress nonsustained ventricular arrhythmias after myocardial infarction, demonstrated a higher mortality in patients taking the drug compared with those given the placebo (1) . Not only has CAST focused attention on the potential for late proarrhythmia as well as the negative iso tropic action of antiarrhythmic drugs, but it has stimulat ed a renewed effort to better assess antiarrhythmic drug efficacy and adversity during the preclinical stages of drug development.
Based upon this need, we utilized an isolated, blood perfused canine papillary muscle preparation to precisely study the direct cardiac effects of the class I antiar rhythmic drugs under physiologically stable conditions (2) (3) (4) (5) (6) (7) (8) . An electrically paced preparation was used to measure intraventricular conduction time (IVCT), coro nary blood flow (CBF) and developed tension of the papil lary muscle (DT), while a spontaneously beating prepa ration was used to measure ventricular automaticity rate (VR). Tetrodotoxin (TTX), the prototypic Na+ channel blocker (9, 10) , was studied initially. The effects of ver apamil, a prototypic Ca 21 channel blocker (2, 8) , was used for comparison with the class I agents. The effects and relative potency of well-established and new class I drugs were compared with responses observed with TTX and verapamil. We propose that this model for evaluating the multiple effects of a drug on cardiac muscle is an effec tive way to better assess class I agents during antiar rhythmic drug development.
MATERIALS AND METHODS
Experiments were carried out using papillary muscle preparations cross-circulated with the heparinized arterial blood of donor dogs as shown in Fig. 1 , which was essen tially the same as the previous reports (2 8 ). All experi ments were performed in accordance with Guidelines for Animal Experiments, Yamanashi Medical University. Fig. 1 . A schematic representation of cross-circulation. The papillary muscle preparation was perfused with the arterial blood of the donor dog. The intraventricular conduction time, coronary blood flow and developed tension of papillary muscle were con tinuously monitored. Drugs were injected intraarterially into the anterior septal artery.
Preparation
The hearts were obtained from mongrel dogs of either sex, weighing approximately 10 kg, which were anesthe tized with sodium pentobarbital (30 mg/kg, i.v.) and given calcium heparin (500 U/kg, i.v.). They were excised after exsanguination and plunged into cold Tyrode's solu tion kept at about 41C. The preparation consisted of the anterior papillary muscle of the right ventricle attached to the interventricular septum. The anterior septal artery, a nutrient artery of the His-Purkinje system and papillary muscle, was directly cannulated. Bipolar electrodes were sutured onto the His bundle region close to the tricuspid valves for the electrical stimulation, and other bipolar electrodes were attached on the apex of the papillary mus cle for a record of the electrograms. Respiration was controlled using a dog respirator (607; Harvard, Millis, MA, USA). The systemic blood pres sure, heart rate and electrocardiograms were monitored continuously with a polygraph (361-6; NEC San-ei Instru ments, Tokyo).
Cross circulation
The preparation was placed in a double-wall glass jack et maintained at 381C by circulating warm water, and it was perfused with arterial blood from the carotid artery of the donor dog. Perfusion pressure was kept at 120 mmHg with a peristaltic pump (7553-00; Cole-Parmer, Chicago, IL, USA) and a Starling's pneumatic resistance placed parallel to the perfusion circuit. Venous blood from the preparation and excess blood passing through the pneumatic resistance were collected in a blood reser voir and returned to the jugular vein of the donor dog.
Effects of drugs on IVCT, CBF and DT
After equilibration of 1 hr, the preparation was electri cally driven by a stimulator (DHM-226-3; Dia Medical, Tokyo) and an isolation unit (DPS-110, Dia Medical). The stimulation pulses were rectangular in shape, 1 3 V (about 20% above the threshold voltage) and 5-msec dura tion at a cycle length of 500 msec for all drugs. Cycle lengths of 400 and 300 msec were also used for lidocaine and mexiletine to assess the use-dependent effect of drugs in this preparation.
IVCT as an interval between the stimulus artifact and distal electrogram at the tip of the papillary muscle was measured continuously by an auto matic interval meter (DHM-226-1, Dia Medical) with 1 msec of analysis pitch. The rate of CBF through the an terior septal artery was continuously monitored with an electromagnetic flowmeter (MVF1100; Nihon Kohden, Tokyo). DT preloaded with a 2-g weight was measured isometrically using a force displacement transducer (DRM-100S, Dia Medical). Effects of procainamide (1 3000 ug), disopyramide (1-1000 ug), lidocaine (1-1000 ug), mexiletine (1-1000 ug), flecainide (1 300 ug), ME3202 (1-1000 ug), AN-132 (1-1000 ug), TTX (0.1-10 ug) and verapamil (0.1-10 ug) on these three parameters were simultaneously assessed and were record ed on a rectilinear recorder (8K231 S, NEC San-ei Instru ments).
Effects of drugs on VR
As the papillary muscle preparation had an automa ticity originating in the Purkinje fiber of the ventricular septum (2), it showed a spontaneous regular contraction when the electrical stimulation was stopped (4, 5, 7) . Using this spontaneously beating papillary muscle prepa ration, VR was measured with a cardiotachograph (1321, NEC San-ei Instruments) triggered by bipolar electro grams of the papillary muscle. Effects of procainamide (1 3000 gig), disopyramide
(1-1000 pg), lidocaine (1-1000 ttg), mexiletine (1-1000 ttg), flecainide (1-1000 tcg), ME3202 (1-1000 pg), TTX (0.1-10 tcg) and ver apamil (0.1-10 pg) on VR were assessed and were record ed on a rectilinear recorder (8K231 S, NEC San-ei Instru ments).
Drugs
Drugs used in this study were as follows: procainamide hydrochloride (Dai-ichi, Tokyo), disopyramide phos phate (Roussel through Chugai, Tokyo), lidocaine hydrochloride (Fujisawa, Osaka), mexiletine hydrochlo ride (Bohringer Ingelheim through Tanabe, Osaka), flecainide acetate (Eisai, Tokyo), ME3202; 2-[2-(diiso propylamino) ethyl ] 4 methyl 2 (2 pyridyl) pentan amide (Meiji, Tokyo), AN-132; 3-(diisopropylamino ethyl amino)-2, 6-dimethylpropionanilide 2H3PO4 (Chugai, Tokyo), TTX (Sigma, St. Louis, MO, USA) and ver apamil hydrochloride (Eisai, Tokyo). A 10-til volume of drug solution was injected into the anterior septal artery over 4 sec with a microsyringe (Terumo, Tokyo). The blood containing the injected drug was discarded after going through the papillary muscle preparation. Given the relatively small doses of drugs administered to the preparations compared to those needed in a whole intact animal, multiple drug doses can be relatively rapidly stud ied in the same preparation.
Data analysis and statistics
The drug effect after intraarterial administration was assessed from both the peak response and its duration. Peak responses in each parameter are expressed as a per cent of their basal values before injection. ED5O(IVCT), the dose (pg) of drugs causing a 50% increase in IVCT; ED5O(CBF), the dose (pg) causing a 50% increase in CBF; ED5O(DT), the dose (tcg) causing a 50% decrease in DT; ED50(vR), the dose (gig) causing a 50% decrease in VR, were calculated from dose-response curves by the least squares method. The pharmacodynamics of drugs was as sessed using onset half time (OHT) and recovery half time (RHT), as follows: OHT is the time (sec) required to reach the peak effect from 1 /2 peak effect in each cardiac variable. OHT(IVCT), OHT(CBF), OHT(DT) and OHT(VR) in dicate the onset half time to increase IVCT and CBF and to decrease DT and VR, respectively. RHT is the time (sec) required to return to 1/2 peak effect from the peak effect in each cardiac variable. RHT(IVCT), RHT(CBF), RHT(DT) 
RESULTS
Baseline characteristics of the preparation When paced at a cycle length of 500 msec, the prepara tions showed a basal IVCT of 41:1--l msec, CBF of 5.4±0.3 ml/min and DT of 6.3_.E0.2 g (n=53). When paced at a cycle length of 400 msec, the preparations showed a basal IVCT of 44± 1 msec, CBF of 4.1 ±0.3 ml/min, DT of 5.0±0.4 g (n=12). When paced at a cycle length of 300 msec, the preparations showed a basal IVCT of 45 ± 1 msec (n=12), and 10 preparations out of 12 showed a pulsus alternans type contraction, which was a regular alteration of DT, despite a regular rhythm. As the distance between the pacing electrodes of the His bun dle and papillary muscle electrodes was about 3 5 cm, the conduction velocity was estimated as about 1.2-2.0 m/sec.
Without pacing, the ventricle spontaneously depola rizes. The basal VR (beats/min) was 41 ±5 (n=6) before procainamide, 41 ± 2 (n = 6) before disopyramide, 40 _±:6 (n=6) before lidocaine, 41±5 (n=6) before mexiletine, 38±4 (n=6) before flecainide, 39±3 (n=6) before ME3202, 36 ± 3 (n = 6) before TTX and 42 ± 5 (n = 6) be fore verapamil. There was no significant difference among the groups.
Effects of TTX and verapamil on IVCT, CBF and DT
Typical experiments showing the effects of TTX and verapamil are shown in Fig. 2 , and dose-response curves are shown in Fig. 3 . Administration of TTX resulted in a dose-dependent prolongation in the IVCT and produced broadening and diminution of amplitude of bipolar elec trograms obtained from the papillary muscle. TTX caused an increase in CBF and a decrease in DT. Mean while, verapamil decreased IVCT slightly, increased CBF significantly and decreased DT followed by a transient increase in all preparations as shown in Fig. 2 . These two drugs were used to establish a relative potency scale of cardiac direct effects for the class I drugs.
Evaluation of the effects of class I drugs on IVCT, CBF and DT in a blood perfused canine papillary muscle As with TTX, seven class I drugs increased IVCT in a dose-dependent manner. The increase in the IVCT after the injection of lidocaine or mexiletine was enhanced by decreasing the cycle length, as shown in Fig. 5A . When paced at a 300-msec driving interval, a second degree con duction block was produced in 1 out of 6 preparations by 100 pg of lidocaine and no preparation by 100 pg of mex iletine, in 2 out of 6 by 300 pg of lidocaine and 1 out of 6 by 300 pg of mexiletine, and in 2 out of 6 by 1000 pg of lidocaine and 2 out of 6 by 1000 pg of mexiletine. The dose causing a 50% (approximately 20 msec) increase in IVCT, ED5O(IVCT), is shown in Table 1 , indicating that the effect of TTX on IVCT was 56-562 times more potent than those of class I drugs; the potency of the effect on IVCT of class I drugs was in the order of flecainide, AN 132, ME3202, disopyramide, lidocaine, mexiletine and procainamide, while lidocaine and mexiletine increased it at rapid driving. The onset half time for IVCT (OHT(IVCT)), which indicates the onset rate after the highest dose of each drug, was extremely slow for flecainide and dis opyramide; intermediate for procainamide, AN-132 and ME3202; and quite fast for mexiletine, TTX and lidocaine, as shown in Table 2 . Recovery half time for IVCT (RHT(IVCT)), which indicates the recovery rate after the highest dose of each drug, was slow for flecainide, disopyramide, ME3202 and AN-132; intermediate for procainamide; fast for lidocaine, mexiletine and TTX, as shown in Table 2 . Table 2 . As with TTX and verapamil, the class I agents decreased DT in a dose-dependent manner, although procainamide produced a transient increase followed by a decrease in 4 out of 6 preparations as shown in Fig. 4 . Decreasing the drive cycle length hardly affected the nega tive inotropic effects of lidocaine and mexiletine as shown in Fig. 5C . The ED5o(DT) values are shown in Table 1 , in dicating that the potency of the negative inotropic effect of class I drugs was in the order of flecainide, mexiletine, lidocaine, disopyramide, AN-132, ME3202 and procainamide. The onset half time for DT (OHT(DT)), which indicates the onset speed of the inotropic response to the highest dose of each drug, was slowest for dis opyramide followed by verapamil and flecainide, and quite fast for other drugs, as shown in Table 2 . D,) ), which indicates the recov ery speed of the tension response to the highest dose of each drug, was extremely slow for disopyramide followed by flecainide; and it became faster in the order of ver apamil, lidocaine, procainamide, ME3202, mexiletine, AN-132, and was the fastest for TTX, as shown in Table  2 .
Effects of TTX and verapamil on VR Typical experiments showing the effects of TTX and verapamil are shown in Fig. 6A , and dose-response curves are shown in Fig. 6 , B and C, respectively. TTX decreased VR in a dose-dependent manner, but verapamil failed to produce a significant change in VR even in doses that produced significant vasodilator and negative iso tropic effects.
Evaluation of the effects of class I drugs on VR using this model Typical recordings of procainamide, disopyramide, mexiletine and ME3202 are shown in Fig. 7 . Dose response curves of class I drugs are shown in Fig. 8 . As with TTX, all the class I drugs decreased VR in a dose-de pendent manner. The ED50(VR) values are shown in Table  1 ; and the order of the potency of the effect on VR of class I drugs was mexiletine, lidocaine, AN-132, ME3202, flecainide, disopyramide and procainamide. The onset half time for VR (OHT(VR)), which indicates the onset speed of the response to the highest dose of each drug, was fast for all drugs, as shown in Table 2 . The recovery half time for VR (RHT(VR)), which indicates the recovery speed of the responses to the highest dose of each drug, was also fast for all drugs, as shown in Table 2 .
The correlation between the drug-induced change of each parameter and antiarrhythmic potency
We have previously described the use of the classical digitalis-induced and coronary ligation-induced arrhyth mia models to assess the antiarrhythmic activity of class I drugs (11) . Correlation between EDSO(IVCT) in this study and antiarrhythmic effects on the in vivo canine digitalis arrhythmia of class I drugs expressed by the anti arrhythmic IC50 plasma concentrations from our earlier reports (11) is shown in Fig. 9 . EDSO(IVcT) correlated well with the antiarrhythmic concentrations of digitalis ar rhythmias, while other ED50 values showed poor correla tions. There was also a good correlation between EDSO(IVCT) and the antiarrhythmic IC50 plasma concentra tions of coronary ligation arrhythmia (data are not shown). 
DISCUSSION
The present study was designed to test the potential util ity of a blood-perfused papillary muscle preparation as a means to assess the pharmacological efficacy and adver sity of the class I antiarrhythmic drugs. Although this preparation has been described previously, it has not been utilized as a tool to assess and compare the relative po tencies and differences within a class of antiarrhythmic drugs. The results of this study demonstrate that the rela tive potencies of the class I agents on IVCT, CBF, DT and VR can be readily assessed and varied significantly. Furthermore, the results demonstrate that specific prop erties of new agents, still in the developmental phase, can be readily and quantitatively assessed in a model in which the electrophysiological properties are known to be simi lar to those observed in humans (2 8) .
Under physiologically maintained electrical and mechanical conditions, 1) use-dependency and phar macodynamics of sodium channel block, 2) changes in contraction, coronary blood flow and idioventricular automaticity, and 3) correlation between cardiac direct effects and antiarrhythmic activity were assessed with this model. Use-dependency: The use-dependent effects of lido caine and mexiletine were assessed by using three differ ent driving cycle lengths. The effects on IVCT were enhanced by higher stimulation frequency. These results are well in accordance with the previous in vitro and in vivo studies (3, 5, 6, 12-15 ). Since changes in V..ax were generally proportional to changes in the square of the con duction velocity (16) , the use-dependency in the present experiment can be also interpreted within the framework of the "modulated receptor hypothesis" proposed by Hondeghem and Katzung to explain the interaction be tween class I antiarrhythmic drugs and the cardiac sodium channels (17) .
Kinetics of use-dependent sodium channel block (phar macodynamics): To estimate the onset and recovery rate of drugs in our preparation, we measured OHT and RHT, respectively. For example, disopyramide and flecainide showed slow onset and long-lasting effects on IVCT after bolus injections, while the reverse was true for lidocaine and mexiletine in this study. The order of speed estimated by OHT(IVCT) and RHT(IVCT) in the present study was in good accordance with that classified by the onset rate for the use dependent block and the recovery time constant from the use dependent block in previous reports, respectively (14, (18) (19) (20) . Therefore, these find ings indicate that the classification by the kinetics of bind ing and dissociation of class I drugs with Na+ channels is also valid in our preparation. . Lidocaine and mexiletine were tested at two faster driving rates to examine effects on intraventricular conduc tion time. Other drugs were tested at 500-msec driving interval. An tiarrhythmic plasma concentrations were calculated from our earlier reports (11, 39, 40) . P: procainamide, D: disopyramide, L4: lido caine at 400-msec driving interval, L3: lidocaine at 300-msec driving interval, M4: mexiletine at 400-msec driving interval, M3: mexiletine at 300-msec driving interval, F: flecainide, ME: ME3202, AN: AN 132.
Negative inotropic effects: Negative inotropic effects of antiarrhythmic drugs present a particular concern clinical ly, since it has been considered one of the risk factors for the higher mortality rate in the CAST trial. Seven class I antiarrhythmic drugs and TTX dose-dependently decreased DT, which is in good accordance with the previ ous reports (3, 5 7, 14, 21 24) . The negative inotropic effect of class I antiarrhythmic drugs is considered to represent the sum of their Na+ channel blocking and addi tional drug-dependent inotropic properties (21, 25 27 ). The Na+ channel blocking effect of class I drugs has been thought to increase cardiac transmembrane Na+ concen tration gradient, and this effect may increase the Na/Ca exchange mechanism, resulting in the decrease in the in tracellular Ca concentration (21, 25 27) . It has been sug gested that the inhibition of slow inward Ca 21 current (21) and inhibition of Ca 2+ efliux from the sarcoplasmic reticulum (28) would be also responsible for their negative inotropic effects.
Procainamide and verapamil decreased the contraction of papillary muscle followed by a transient increase, which is in accordance with the previous report (7, 8) . As shown in an earlier report (7), the positive inotropic phase of procainamide was not modified by pretreatment with 10-30 pg of propranolol, which is the sufficient dose to block the same degree of positive inotropic action by norepinephrine. The precise mechanism of this transient positive inotropic response by procainamide and ver apamil is still unknown.
One example of the way this model can be used is to study more subtle yet potentially important negative inotropic effects of class I drugs. For example, lidocaine and mexiletine exerted negative inotropic action while the intraventricular conduction remained unaffected, although the negative inotropic actions of lidocaine and mexiletine are commonly said to be clinically insignificant (29, 30) . As shown in this experiment, bolus administra tion of these drugs produced significant transient depres sion of ventricular contractility, which was comparable to that produced by disopyramide.
Effects on coronary blood flow: The class I antiar rhythmic drugs increase CBF (3, 5, 6, 12, 31) , and these effects can be easily assessed in this model. To analyze fur ther the effects of class I drugs on CBF, we compared their effects with TTX and verapamil. TTX slightly in creased CBF, which is compatible with the conclusion by Lipsius et al. (32) , while verapamil showed a potent and long-lasting coronary vasodilator effect. Although it is quite natural to expect that the coronary vasodilator effects of class I drugs may lead to cardioprotection as well as to antiarrhythmic activity (12, 33) , the coronary effects by class I drugs may be less important, because the duration of the effects of class I drugs on CBF were tran sient compared with their effects on IVCT, DT and VR and much weaker than the coronary effect of verapamil.
Changes in idioventricular automaticity: Changes in the spontaneous VR were studied. Class I antiarrhythmic drugs and TTX used in this study decreased VR in a dose dependent manner, whereas verapamil virtually did not affect it in doses that suppressed the DT and increased the CBF. Similar results were reported previously (2, 5, 7, (34) (35) (36) (37) (38) . The ventricular automaticity observed in un paced papillary muscle preparations has been thought to originate in Purkinje fibers in the ventricular septum (2) . Consequently, the inhibition of the VR by TTX and class I drugs is most likely caused by suppression of the pacemaker current in Purkinje fibers manifesting "nor mal" automaticity. The mechanism of action of lidocaine responsible for this automaticity has been ascribed to their blockade of the pacemaker current activated by hyperpolarization (Ih) (34) . This effect of class I drug may reflect its antiarrhythmic activity on the limited ar rhythmias where "normal" automaticity of Purkinje fiber may play a significant role as an arrhythmogenic mecha nism. Lidocaine and mexiletine should be administered with caution in patients with idioventricular rhythm without sinus beats, because a bolus administration of these drugs may produce potent depression of VR, as shown in these experiments.
Correlation between cardiac direct effects and antiar rhythmic activity: We examined the correlation between the intraarterial ED50 doses in this study and the antiar rhythmic IC50 plasma concentrations obtained in our previous canine arrhythmia model studies, namely digi talis and coronary ligation-induced arrhythmias (11, 39, 40) . Although these arrhythmias most likely are caused by triggered activity from delayed after depolarizations, ab normal automaticity and/or re-entrant excitation in very depolarized tissues (11, 39, 40) , a good correlation was found only between EDSO(IVCT) in this current study and IC50 of two different types of arrhythmia models. The results may indicate that the antiarrhythmic mechanism of class I drugs in the canine arrhythmia models is closely related to the suppression of the normal intraventricular conduction. However, caution must be taken on the inter pretation of the in vitro results of the present study, which were obtained on "normal" cardiac tissue. In summary, the canine isolated, blood-perfused papil lary muscle preparation can be used to assess use-depend ency, kinetics of sodium channel block, inotropic effects of class I drugs as well as the effects on coronary blood flow, intraventricular conduction and ventricular auto maticity. Meanwhile, the model is not suitable for exten sive investigation and molecular mechanisms because of mutual complex interactions of multiple parameters. Class I antiarrhythmic drugs have multiple pharma cological effects on ventricular tissue, including inhibition of conduction, automaticity and contraction and coro nary vasodilator effects, which were similar to those of TTX and were in good accordance with previous reports using different species (13-16, 18, 19, 21, 26, 32, 34) . Although these drugs may exert their antiarrhythmic effects through a combination of these actions, the effect on conduction may be the most relevant for the antiarrhythmic actions. Use of this model facilitates the comparison of direct cardiac effects of class I drugs and the data shown in this paper provide convenient guidelines in predicting possible effectiveness and potential adverse effects of the new anti arrhythmic drugs.
